A phase I trial of ALG 1001 in patients with advanced stage diabetic macular oedema.
Phase of Trial: Phase I
Latest Information Update: 02 Dec 2011
At a glance
- Drugs ALG 1001 (Primary)
- Indications Diabetic macular oedema
- Focus Adverse reactions; Therapeutic Use
- 21 Oct 2011 New trial record